DOES LIMITING HOTSPOTS OUTSIDE THE GTV DECREASE THE RISK OF VERTEBRAL COMPRESSION FRACTURE IN PATIENTS BEING TREATED WITH SPINE SBRT? A SINGLE INSTITUTION EXPERIENCE
Zhang Hao (Jim) Li , Adrian Wai Chan , Alanah M. Bergman , Haley Patrick , Mitchell Liu , Emma M. Dunne
{"title":"DOES LIMITING HOTSPOTS OUTSIDE THE GTV DECREASE THE RISK OF VERTEBRAL COMPRESSION FRACTURE IN PATIENTS BEING TREATED WITH SPINE SBRT? A SINGLE INSTITUTION EXPERIENCE","authors":"Zhang Hao (Jim) Li , Adrian Wai Chan , Alanah M. Bergman , Haley Patrick , Mitchell Liu , Emma M. Dunne","doi":"10.1016/S0167-8140(25)04755-3","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose:</h3><div>Vertebral compression fracture (VCF) is one of the most common and challenging adverse events following stereotactic body radiation (SBRT) to the spine. Among the many possible predictive factors for VCF, radiation dose per fraction has consistently been found to increase the risk. In response to this, our institution has recently adopted a new constraint to limit dose in the PTV – (GTV+2mm) region to <110% under the hypothesis that limiting the hotspots (HS) outside the GTV will decrease the risk of VCF. This study aims to test this hypothesis and evaluate the effects of this new constraint on VCF rates and local control.</div></div><div><h3>Materials and Methods:</h3><div>A retrospective review was conducted of all patients treated with SBRT between October 2014 and December 2022 for de novo spinal metastases. Patients with pre- and post-treatment MRIs were selected for the study cohort. Clinical, dosimetric, and survival data were collected, and survival analyses were performed using the Kaplan-Meier method to compare outcomes between plans that respected and exceeded the HS constraint.</div></div><div><h3>Results:</h3><div>80 patients underwent SBRT treatment to 117 spine segments, 35 of which respected the PTV-(GTV+2mm) HS constraint. The median age was 64 (range: 28-83). At a median follow up of 33 months, 36 patients died. The mean overall survival was 60 months (95% CI: 50-69 months). The cumulative risk of VCF at 24 months was 6% (95% CI: 0-15%) for segments treated with the HS-limiting constraint and 19% (95% CI: 9-28%) for those without (p=0.10). Local control at 24 months was 88% (95% CI: 76%-99%) and 82% (95% CI: 73-91%), respectively (p=0.31).</div></div><div><h3>Conclusions:</h3><div>Although our small sample size did not show any significant differences, the lower VCF rates observed suggest a potential benefit of applying the PTV – (GTV+2mm) <110% constraint in reducing VCF rates associated with SBRT. Future prospective studies could be performed to further evaluate this.</div></div>","PeriodicalId":21041,"journal":{"name":"Radiotherapy and Oncology","volume":"210 ","pages":"Page S41"},"PeriodicalIF":5.3000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiotherapy and Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0167814025047553","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose:
Vertebral compression fracture (VCF) is one of the most common and challenging adverse events following stereotactic body radiation (SBRT) to the spine. Among the many possible predictive factors for VCF, radiation dose per fraction has consistently been found to increase the risk. In response to this, our institution has recently adopted a new constraint to limit dose in the PTV – (GTV+2mm) region to <110% under the hypothesis that limiting the hotspots (HS) outside the GTV will decrease the risk of VCF. This study aims to test this hypothesis and evaluate the effects of this new constraint on VCF rates and local control.
Materials and Methods:
A retrospective review was conducted of all patients treated with SBRT between October 2014 and December 2022 for de novo spinal metastases. Patients with pre- and post-treatment MRIs were selected for the study cohort. Clinical, dosimetric, and survival data were collected, and survival analyses were performed using the Kaplan-Meier method to compare outcomes between plans that respected and exceeded the HS constraint.
Results:
80 patients underwent SBRT treatment to 117 spine segments, 35 of which respected the PTV-(GTV+2mm) HS constraint. The median age was 64 (range: 28-83). At a median follow up of 33 months, 36 patients died. The mean overall survival was 60 months (95% CI: 50-69 months). The cumulative risk of VCF at 24 months was 6% (95% CI: 0-15%) for segments treated with the HS-limiting constraint and 19% (95% CI: 9-28%) for those without (p=0.10). Local control at 24 months was 88% (95% CI: 76%-99%) and 82% (95% CI: 73-91%), respectively (p=0.31).
Conclusions:
Although our small sample size did not show any significant differences, the lower VCF rates observed suggest a potential benefit of applying the PTV – (GTV+2mm) <110% constraint in reducing VCF rates associated with SBRT. Future prospective studies could be performed to further evaluate this.
期刊介绍:
Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, translational studies, epidemiological outcomes, imaging, dosimetry, and radiation therapy planning, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as data science in radiation oncology and physics aspects relevant to oncology.Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published.